Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease… Grant US-10111849-B2 United States of America 30 Oct 2018
Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function Grant US-10105338-B2 United States of America 23 Oct 2018
Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease… Grant US-9603823-B2 United States of America 28 Mar 2017
Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function Grant US-9175345-B2 United States of America 03 Nov 2015
Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders Grant US-9125881-B2 United States of America 08 Sep 2015
Treatment of cancer by administration of perfluorooctanoic acid Grant US-8487003-B2 United States of America 16 Jul 2013
Use of medium chain triglycerides for the treatment and prevention of alzheimer'S disease… Grant US-8426468-B2 United States of America 23 Apr 2013
Use of ketogenic compounds for treatment of age-associated memory impairment Application EP-2500017-A1 European Patent Office 19 Sep 2012
Method to reduce oxidative damage and improve mitochondrial efficiency Application EP-2468273-A2 European Patent Office 27 Jun 2012
Genes expressed in treated human C3A liver cell cultures Grant US-6727066-B2 United States of America 27 Apr 2004